These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19735100)

  • 1. DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.
    Liang QL; Wang BR; Li GH
    J Zhejiang Univ Sci B; 2009 Sep; 10(9):675-82. PubMed ID: 19735100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.
    Zong L; Chen P; Wang DX
    World J Gastroenterol; 2014 Apr; 20(15):4440-5. PubMed ID: 24764685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW; Wu YL; Peng SY
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma.
    Tan HY; Liu J; Wu SM; Luo HS
    World J Gastroenterol; 2005 Aug; 11(30):4689-92. PubMed ID: 16094711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Tcf-4, MMP7 and Survivin in Colorectal Cancer and Its Clinical Significance].
    Ou YR; Jing GY; Wu Q; Gao S; Cheng ZN; Dong Xiu-qin
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 46(4):554-9. PubMed ID: 26480657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
    Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
    Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas.
    Zhou J; Song SD; Li DC; Zhou J; Zhu DM; Zheng SY
    Asian Pac J Cancer Prev; 2012; 13(2):719-24. PubMed ID: 22524850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
    Chen G; Luo D
    Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.
    Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z
    J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
    Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.
    Zhou J; Song S; Li D; He S; Zhang B; Wang Z; Zhu X
    World J Surg Oncol; 2014 Mar; 12():52. PubMed ID: 24597666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of survivin gene and PTEN protein in colorectal adenocarcinoma].
    Yang D; Zhu YQ; Qi J
    Ai Zheng; 2004 Mar; 23(3):306-9. PubMed ID: 15025964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
    Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
    World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer.
    Mild G; Bachmann F; Boulay JL; Glatz K; Laffer U; Lowy A; Metzger U; Reuter J; Terracciano L; Herrmann R; Rochlitz C
    Int J Cancer; 2002 Nov; 102(3):254-7. PubMed ID: 12397645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression in colorectal adenocarcinoma using tissue microarray.
    Abd El-Hameed A
    J Egypt Natl Canc Inst; 2005 Mar; 17(1):42-50. PubMed ID: 16353082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression.
    Fan LF; Dong WG; Jiang CQ; Qian Q; Yu QF
    Int J Colorectal Dis; 2008 Nov; 23(11):1057-64. PubMed ID: 18704463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
    Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
    Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.